- Home
- IMXI vs AUTL Comparison
IMXI vs AUTL Comparison
Compare IMXI & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- AUTL
- Stock Information
- Founded
- IMXI 1994
- AUTL 2014
- Country
- IMXI United States
- AUTL United Kingdom
- Employees
- IMXI N/A
- AUTL N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMXI Technology
- AUTL Health Care
- Exchange
- IMXI Nasdaq
- AUTL Nasdaq
- Market Cap
- IMXI 619.2M
- AUTL 609.4M
- IPO Year
- IMXI N/A
- AUTL 2018
- Fundamental
- Price
- IMXI $21.04
- AUTL $2.22
- Analyst Decision
- IMXI Buy
- AUTL Strong Buy
- Analyst Count
- IMXI 6
- AUTL 3
- Target Price
- IMXI $27.50
- AUTL $10.20
- AVG Volume (30 Days)
- IMXI 142.5K
- AUTL 1.4M
- Earning Date
- IMXI 02-25-2025
- AUTL 03-13-2025
- Dividend Yield
- IMXI N/A
- AUTL N/A
- EPS Growth
- IMXI 21.49
- AUTL N/A
- EPS
- IMXI 1.80
- AUTL N/A
- Revenue
- IMXI $665,673,000.00
- AUTL $10,091,000.00
- Revenue This Year
- IMXI $2.65
- AUTL $851.83
- Revenue Next Year
- IMXI $2.82
- AUTL $264.18
- P/E Ratio
- IMXI $11.72
- AUTL N/A
- Revenue Growth
- IMXI 3.79
- AUTL 82.71
- 52 Week Low
- IMXI $16.17
- AUTL $2.07
- 52 Week High
- IMXI $23.28
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- IMXI 55.16
- AUTL 38.18
- Support Level
- IMXI $19.73
- AUTL $2.18
- Resistance Level
- IMXI $20.64
- AUTL $2.38
- Average True Range (ATR)
- IMXI 0.47
- AUTL 0.16
- MACD
- IMXI 0.04
- AUTL 0.01
- Stochastic Oscillator
- IMXI 78.23
- AUTL 7.94
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.